Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Carpenter

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetineAlan Apter, Alan Lipschitz, Regan Fong, et al.
Annals of Surgical Oncology|July 6, 2026
Functional Outcomes for Breast Cancer Survivors Following an Intense Resistance Training Program Based on Surgical Management of the Breast and AxillaLucia Castro Hernandez, David J Carpenter, Thomas B Julian, et al.
Advances in Radiation Oncology|May 8, 2023
Clinical Factors Associated With 30-Day Mortality Among Patients Undergoing Radiation Therapy for Brain MetastasesDivya Natesan, David J Carpenter, Will Giles, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 25, 2006
Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trialGraham J Emslie, Karen Dineen Wagner, Stan Kutcher, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 27, 2004
Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trialDaniel A Geller, Karen Dineen Wagner, Graham Emslie, et al.
Archives of General Psychiatry|November 3, 2004
A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorderKaren Dineen Wagner, Ray Berard, Murray B Stein, et al.
JCO Oncology Practice|May 7, 2025
EXERT-BCN: An Exercise Regimen Designed to Improve Body Composition, Functional Capacity, and Strength After Treatment for Breast Cancer With Nutrition OptimizationDavid J Carpenter, Chris Peluso, Christie Hilton, et al.
Plastic and Reconstructive Surgery. Global Open|July 24, 2019
Computational Analysis of the Mature Unilateral Cleft Lip Nasal Deformity on Nasal PatencyDennis O Frank-Ito, David J Carpenter, Tracy Cheng, et al.
Journal of Experimental Zoology. Part A, Ecological and Integrative Physiology|December 8, 2025
The Individual and Combined Effects of Warming and Atrazine on Lithobates pipiens Phenotypes: Implications for Frog DeclinesMelody J Gavel, Mark R Forbes, Derek D N Smith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2008
Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxineMichael J Owens, Stan Krulewicz, Jeffrey S Simon, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetineAlan Apter, Alan Lipschitz, Regan Fong, et al.
Annals of Surgical Oncology|July 6, 2026
Functional Outcomes for Breast Cancer Survivors Following an Intense Resistance Training Program Based on Surgical Management of the Breast and AxillaLucia Castro Hernandez, David J Carpenter, Thomas B Julian, et al.
Advances in Radiation Oncology|May 8, 2023
Clinical Factors Associated With 30-Day Mortality Among Patients Undergoing Radiation Therapy for Brain MetastasesDivya Natesan, David J Carpenter, Will Giles, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 25, 2006
Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trialGraham J Emslie, Karen Dineen Wagner, Stan Kutcher, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 27, 2004
Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trialDaniel A Geller, Karen Dineen Wagner, Graham Emslie, et al.
Archives of General Psychiatry|November 3, 2004
A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorderKaren Dineen Wagner, Ray Berard, Murray B Stein, et al.
JCO Oncology Practice|May 7, 2025
EXERT-BCN: An Exercise Regimen Designed to Improve Body Composition, Functional Capacity, and Strength After Treatment for Breast Cancer With Nutrition OptimizationDavid J Carpenter, Chris Peluso, Christie Hilton, et al.
Plastic and Reconstructive Surgery. Global Open|July 24, 2019
Computational Analysis of the Mature Unilateral Cleft Lip Nasal Deformity on Nasal PatencyDennis O Frank-Ito, David J Carpenter, Tracy Cheng, et al.
Journal of Experimental Zoology. Part A, Ecological and Integrative Physiology|December 8, 2025
The Individual and Combined Effects of Warming and Atrazine on Lithobates pipiens Phenotypes: Implications for Frog DeclinesMelody J Gavel, Mark R Forbes, Derek D N Smith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2008
Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxineMichael J Owens, Stan Krulewicz, Jeffrey S Simon, et al.
Pageof 6